284 related articles for article (PubMed ID: 16106478)
1. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
Saiz-Ruiz J; Montes JM; Ibáñez A; Díaz M; Vicente F; Pelegrín C; Viñas R; Arias F; Carrasco JL; Ferrando L
Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
[TBL] [Abstract][Full Text] [Related]
2. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
4. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
Yoon SJ; Pae CU; Kim DJ; Namkoong K; Lee E; Oh DY; Lee YS; Shin DH; Jeong YC; Kim JH; Choi SB; Hwang IB; Shin YC; Cho SN; Lee HK; Lee CT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1196-201. PubMed ID: 16624467
[TBL] [Abstract][Full Text] [Related]
8. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older.
Nelson JC; Hollander SB; Betzel J; Smolen P;
Int J Geriatr Psychiatry; 2006 Sep; 21(9):898-901. PubMed ID: 16955423
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
Gambi F; De Berardis D; Campanella D; Carano A; Sepede G; Salini G; Mezzano D; Cicconetti A; Penna L; Salerno RM; Ferro FM
J Psychopharmacol; 2005 Sep; 19(5):483-7. PubMed ID: 16166185
[TBL] [Abstract][Full Text] [Related]
11. Care of the sexually active depressed patient.
Hirschfeld RM
J Clin Psychiatry; 1999; 60 Suppl 17():32-5; discussion 46-8. PubMed ID: 10446740
[TBL] [Abstract][Full Text] [Related]
12. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction.
Atmaca M; Kuloglu M; Tezcan E; Buyukbayram A
Hum Psychopharmacol; 2003 Jun; 18(4):277-80. PubMed ID: 12766932
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
[TBL] [Abstract][Full Text] [Related]
14. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
16. Onset of antidepressant action: a pharmacological question?
Rojo JE; Gibert K; Cobo J; Rodriguez-Cano E; Vallejo J
Hum Psychopharmacol; 2005 Aug; 20(6):425-33. PubMed ID: 16106477
[TBL] [Abstract][Full Text] [Related]
17. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith WT; Glaudin V; Panagides J; Gilvary E
Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
20. Depressed in-patients respond differently to imipramine and mirtazapine.
Bruijn JA; Moleman P; Mulder PG; van den Broek WW
Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]